KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	15,422	15,021	13,886	19,394	26,994	27,445
Short-Term Investments	1,195	1,493	99	-	500	3,399
Cash & Short-Term Investments	16,617	16,514	13,985	19,394	27,494	30,844
Cash Growth	14.64%	18.08%	-27.89%	-29.46%	-10.86%	-6.30%
Receivables	42,918	47,541	47,672	47,250	41,636	40,409
Inventory	68,695	65,730	53,470	48,025	42,217	38,568
Other Current Assets	5,736	6,349	4,183	4,361	5,029	4,206
Total Current Assets	133,966	136,134	119,310	119,030	116,376	114,027
Property, Plant & Equipment	30,136	30,303	28,950	25,834	24,334	23,896
Long-Term Investments	21,235	21,831	23,882	24,469	27,140	25,074
Other Intangible Assets	4,561	4,757	5,088	5,393	3,289	3,785
Long-Term Deferred Tax Assets	670	591	448	1,316	783	343
Other Long-Term Assets	1	2	1	3	2	1
Total Assets	190,569	193,618	177,679	176,045	171,924	167,126
Accounts Payable	15,983	15,517	14,265	13,762	10,896	6,985
Accrued Expenses	1,251	2,226	2,198	2,182	2,295	2,206
Short-Term Debt	6,100	7,400	10,100	10,300	10,300	10,300
Current Portion of Long-Term Debt	200	200	10,200	-	-	-
Current Portion of Leases	-	135	87	134	147	137
Current Income Taxes Payable	745	3,176	923	2,027	530	476
Other Current Liabilities	8,155	6,457	7,718	6,578	8,014	7,303
Total Current Liabilities	32,434	35,111	45,491	34,983	32,182	27,407
Long-Term Debt	20,185	20,235	435	10,636	10,836	11,036
Long-Term Leases	-	469	124	207	341	409
Long-Term Deferred Tax Liabilities	63	59	185	-	175	293
Other Long-Term Liabilities	1,257	885	545	1,038	998	736
Total Liabilities	54,416	57,334	46,897	50,585	47,417	42,465
Common Stock	700	700	700	700	700	700
Additional Paid-In Capital	4,752	4,752	4,752	4,752	4,752	4,752
Retained Earnings	131,317	142,789	136,774	134,396	132,710	132,557
Treasury Stock	-5,928	-17,349	-17,350	-17,666	-17,671	-17,671
Comprehensive Income & Other	5,312	5,392	5,906	3,278	4,016	4,323
Shareholders' Equity	136,153	136,284	130,782	125,460	124,507	124,661
Total Liabilities & Equity	190,569	193,618	177,679	176,045	171,924	167,126
Total Debt	26,485	28,439	20,946	21,277	21,624	21,882
Net Cash (Debt)	-9,868	-11,925	-6,961	-1,883	5,870	8,962
Net Cash Growth	-	-	-	-	-34.50%	-3.89%
Net Cash Per Share	-171.77	-207.58	-121.29	-32.86	102.44	156.42
Filing Date Shares Outstanding	57.45	57.46	57.45	57.3	57.3	57.3
Total Common Shares Outstanding	57.45	57.46	57.45	57.3	57.3	57.3
Working Capital	101,532	101,023	73,819	84,047	84,194	86,620
Book Value Per Share	2369.99	2371.97	2276.50	2189.38	2172.82	2175.51
Tangible Book Value	131,592	131,527	125,694	120,067	121,218	120,876
Tangible Book Value Per Share	2290.59	2289.18	2187.93	2095.27	2115.43	2109.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.